Abstract
Background
Pelvic recurrent rectal cancer is still a challenging clinical problem, and patients generally have a dismal prognosis and a poor quality of life. Surgical resection represents the only potentially curative treatment; neoadjuvant treatments are presently being taken into consideration to increase the resectability rate and to improve long-term survival.
Methods
Among 157 patients observed with recurrent rectal cancer, a series of 58 patients who underwent surgical exploration with curative intent for isolated local recurrence at a single referral institution was retrospectively analyzed. Demographic, pathologic, and therapeutic factors were evaluated to assess long-term prognosis and local control.
Results
Forty-four (75.9%) of 58 patients underwent surgical resection. The overall 5-year survival rate for patients who underwent surgical resection was 54.2%, whereas none of the unresected patients lived 5 years (P < 0.001). Patients with R0 resection showed a statistically higher 5-year overall survival and local control rate (72.4 and 70.2%, respectively) compared to R1 patients (37.5 and 31.2%, respectively). At multivariate survival analysis, feasibility of a surgical resection and radicality of excision proved to be independent positive prognostic factors. In contrast, increased presalvage carcinoembryonic antigen serum levels, back pain at diagnosis, and an increasing degree of fixation of recurrent disease to the pelvic wall at preoperative computed tomographic scan were statistically significantly linked to decreased overall survival. Preoperative chemoradiation and radicality of the surgical excision independently influenced the local control among surgically resected patients.
Conclusions
Surgical resection still remains the most important therapeutic and prognostic factor for patients with locally recurrent rectal cancer. Multimodal treatments can be safely performed by an experienced team in referral tertiary centers and can result in a safer outcome, better local disease control, and even long-term survival in carefully selected patients.
Similar content being viewed by others
References
Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in respectable rectal cancer. N Engl J Med. 1997;336:980–7.
Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–46.
Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–40.
Hahnloser D, Nelson H, Gunderson LL, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg. 2003;237:502–4.
Heald RJ, Moran BJ, Ryall RDH, et al. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg. 1998;133:894–9.
Pacelli F, Di Giorgio A, Papa V, et al. Preoperative radiotherapy combined with intraoperative radiotherapy improve results of total mesorectal excision in patients with T3 rectal cancer. Dis Colon Rectum. 2004;47:170–9.
Mannaerts GHH, Rutten HJT, Martijn H, et al. Comparison of intraoperative radiation therapy-containing multimodality treatment with historical treatment modalities for locally recurrent rectal cancer. Dis Colon Rectum. 2001;44:1749–58.
Boyle KM, Sagar PM, Chalmers AG, et al. Surgery for locally recurrent rectal cancer. Dis Colon Rectum 2005;48:929–37.
Suzuki K, Dozois RR, Devine RM, et al. Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum. 1996;39:730–6.
Valentini V, Morganti AG, De Franco A, et al. Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: prognostic factors and long term outcome. Cancer. 1999;86:2612–24.
Mohiuddin M, Marks GM, Lingareddy V, et al. Curative surgical resection following reirradiation for recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 1997;40:150–5.
Hashiguchi Y, Sekine T, Sakamoto H, et al. Intraoperative irradiation after surgery for locally recurrent rectal cancer. Dis Colon Rectum. 1999;42:886–95.
Suzuki K, Gunderson LL, Devine RM, et al. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer. 1995;75:939–52.
Pilipshen SJ, Heiweil M, Quan SHQ, et al. Patterns of pelvic recurrence following definitive resection of rectal cancer. Cancer. 1984;53:1354–62.
De Franco A, Vecchioli Scaldazza A, Celi G. Stadiazione mediante imaging delle recidive locali da neoplasia del retto. In: Basilico L, Valentini V, eds. Le recidive pelviche da neoplasia del retto. Diagnosi Stadiazione e Terapia. Vasto: Arte della Stampa-Cannarsa, 1998:36–41.
Radice E, Dozois RR. Locally recurrent rectal cancer. Dig Surg 2001;18:355–62.
Palmer G, Martling A, Cedermark B, et al. A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol. 2006;15:3109–17.
Dresen RC, Gosens MJ, Martijn H, et al. Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol. 2008;15:1937–47.
Salo JC, Paty PB, Guillem J, et al. Surgical salvage of recurrent rectal carcinoma after curative resection: a ten-year experience. Ann Surg Oncol. 1999;6:171–7.
Wiig JN, Tveit KM, Poulsen JP, et al. Preoperative irradiation andsurgery for recurrent rectal cancer. Will inntraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiother Oncol. 2002;62:207–13.
Caricato M, Borzomati D, Ausania F, et al. Prognostic factors after surgery for locally recurrent rectal cancer: an overview. Eur J Surg Oncol. 2006;32:126–32.
Vermaas M, Nuyttens JJME, Ferenschild FTJ, et al. Reirradiation, surgery and IORT for recurrent rectal cancer in previously irradiated patients. Radiother Oncol. 2008;87:357–60.
Miller AR. Multidisciplinary management of recurrent colorectal cancer. Surg Oncol. 1998;7:209–21.
Valentini V, Morganti AG, Gambacorta MA, et al. Preoperative hyperfractioned chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: a multicentric phase II study. Int J Radiat Oncol Biol Phys. 2006;64:1129–39.
Haddock MG, Gunderson L, Nelson H, et al. Intraoperative irradiation for locally recurrent colorectal cancer in previously irradiated patients. Int J Radiat Oncol Biol Phys. 2001;49:1267–74.
Glimelius B. Recurrent rectal cancer. The pre-irradiated primary tumour: can more radiotherapy be given? Colorectal Dis. 2003;5:501–3.
Wanebo HJ, Koness RJ, Vezeridis MP, et al. Pelvic resection of recurrent rectal cancer. Ann Surg. 1994;220:586–97.
Lopez-Koster F, Fazio VW, Vignali A, et al. Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum. 2001;44:173–8.
Nagtegaal ID, van de Velde CJ, Marijnen CA, et al. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol. 2005;23:9257–64.
West NP, Finan PJ, Anderin C, et al. Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol. 2008;26:3517–22.
Holm T, Ljung A, Häggmark T, et al. Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg. 2007;94:232–8.
Acknowledgment
We thank Dr. M. A. Gambacorta for her assistance on oncological data and Dr. G. La Torre, Dr. N. Nicolotti, and Dr. M. Covino for their suggestions for the statistical analyses.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pacelli, F., Tortorelli, A.P., Rosa, F. et al. Locally Recurrent Rectal Cancer: Prognostic Factors and Long-Term Outcomes of Multimodal Therapy. Ann Surg Oncol 17, 152–162 (2010). https://doi.org/10.1245/s10434-009-0737-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-009-0737-5